Table 2.
Patients | N | Anti-ARF (43-141) Negative Response: n (%) | Gray Zone | Anti-ARF (43-141) Positive Response: n (%) |
---|---|---|---|---|
Group III (no infection) | 187 | 186 (99.5%) | 1 (0.5%) | 0 (0%) |
Group IV (HIV infection) | 122 | 120 (98.4%) | 2 (1.6%) | 0 (0%) |
Group V (HBV infection) | 93 | 85 (91.4%) | 7 (7.5%) | 1 (1.1%) |